Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Inozyme Pharma Receives Orphan Drug Designation for INZ-701 in the United States and European Union
Inozyme Pharma Receives Orphan Drug Designation for INZ-701 in the United States and European Union
Inozyme Pharma Receives Orphan Drug Designation for INZ-701 in the United States and European Union
Submitted by
admin
on July 17, 2018 - 9:59am
Source:
CP Wire
News Tags:
Inozyme Pharma
INZ-701
orphan drugs
Headline:
Inozyme Pharma Receives Orphan Drug Designation for INZ-701 in the United States and European Union
snippet:
Company received $49 million dollar funding round in November of 2017
INZ-701 received Orphan Drug Designation in both US and Europe
Do Not Allow Advertisers to Use My Personal information
